Lucerastat Completed Phase 3 Trials for Fabry's Disease Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03425539 | Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease |